PHIBRO ANIMAL HEALTH CORP Net Cash Provided by (Used in) Financing Activities in USD from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Phibro Animal Health Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to Q3 2025.
  • Phibro Animal Health Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2025 was $16.3M.
  • Phibro Animal Health Corp annual Net Cash Provided by (Used in) Financing Activities for 2025 was $207M.
  • Phibro Animal Health Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$6.77M, a 125% decline from 2023.
  • Phibro Animal Health Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $27M, a 65.1% increase from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

PHIBRO ANIMAL HEALTH CORP Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $16.3M +$45.5M Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q3 2024 -$29.2M -$30.5M -2353% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q3 2023 $1.3M -$28M -95.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q3 2022 $29.3M +$21.1M +255% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q3 2021 $8.27M +$1.81M +28% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q3 2020 $6.46M -$57.5M -89.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q3 2019 $63.9M +$52.2M +445% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q3 2018 $11.7M -$6.11M -34.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q3 2017 $17.8M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06

PHIBRO ANIMAL HEALTH CORP Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $207M +$214M Jul 1, 2024 Jun 30, 2025 10-K 2025-08-27
2024 -$6.77M -$33.8M -125% Jul 1, 2023 Jun 30, 2024 10-K 2025-08-27
2023 $27M +$10.6M +65.1% Jul 1, 2022 Jun 30, 2023 10-K 2025-08-27
2022 $16.3M +$33.3M Jul 1, 2021 Jun 30, 2022 10-K 2024-08-28
2021 -$17M -$57.9M -142% Jul 1, 2020 Jun 30, 2021 10-K 2023-08-30
2020 $40.9M +$45M Jul 1, 2019 Jun 30, 2020 10-K 2022-08-24
2019 -$4.11M +$7.67M +65.1% Jul 1, 2018 Jun 30, 2019 10-K 2021-08-25
2018 -$11.8M +$42M +78.1% Jul 1, 2017 Jun 30, 2018 10-K 2020-08-26
2017 -$53.7M -$104M -207% Jul 1, 2016 Jun 30, 2017 10-K 2019-08-27
2016 $50.4M Jul 1, 2015 Jun 30, 2016 10-K 2018-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.